Boletín de la Sociedad Peruana de Medicina Interna - Vol.14 Nº 3 - 2001

 

REFERENCIAS BIBLIOGRÁFICAS

1. Ritz E, Orth SR. Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med 341:1127, 1999

2. Dyck PJ, Kratz KM, Karnes MS, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort The Rochester Diabetic Neuropathy Study. Neurology 43:817, 1993

3. Reiber GE, Pecoraro RE, Koepsell TD. Risk factors for amputation in patients with diabetes mellitus.A Case-Control Study.Ann Intern Med 117:97,1992

4. Harris MI, Hadden WC, Knowler WC, et al. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in the U.S. population aged 20-74 years. Diabetes 36:523, 1987

5. McCance DR, Hanson RL, Charles MA, et al. Comparison of tests forglycated hemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. BMJ 308:1323, 1994

6. McCance DR, Hanson RL, Charles MA, et al. Which test for diagnosing diabetes? Diabetes Care 18:1042, 1995

7. Stern MP Primary prevention of type II diabetes mellitus. Diabetes Care 14:399, 1991

8. Villena CJ. Tratamiento de la diabetes mellitus tipo 2. Diagnóstico 37:95,1998

9. Greene DA, Sima AAF, Stevens MJ, et al. Complications: Neuropathy, pathogenetic considerations. Diabetes Care 15:1902, 1992

10. Newrick PG, Wilson AJ, Jakubowskyi, et al. Sural nerve oxygen tension in diabetes. BMJ 293:1053, 1886

11. Malik RA, Masson EA, Sharma AK, et al. Hypoxic neuropathy: Relevance to human diabetic neuropathy. Diabetología 33:311,19906

12. Tesfaye S, Malik RA, Ward JD. Vascular factors in diabetes neuropathy. Diabetología 37:847, 1994

13. Vinik Al, Holland MT, LeBeau JM, et al. Diabetic neuropathies. Diabetes Care 15:1926, 1992

14. Genuth S. Management of the adult onset diabetic with sulfonylurea drug failure. Endocrinol Metab Clin North Am 21:351,1992

15. Klein R, Klein BE, Moss SE, et al. Glycosilated hemoglobin in a population-based study of diabetes.Am J Epidemiol. 126:415,1987

16. Roman SH, Harris MI. Management of diabetes mellitus from a public health perspective. Endocrinol Metab Clin North Am 26:443, 1997

17. Gómez J, Delgado Baron C, Paz AS, et al. Hemoglobina glicosada en el control del paciente diabético. Diagnóstico 26:79, 1990

18. Williams HR. Textbook of Endocrinology. WB. Saunders Company. Philadelphia, London,Toronto, 1981.

19. Krolewski AS, Warram JH. Epidemiología de la diabetes mellitus. En Joslin Diabetes Mellitus. Philadelphia, Lea and Febiger Pag. 13, 1990

20. Burga NJ, Vera AJ. Estudio de neuropatía periférica sensitiva y factores de riesgo asociados a pie diabético en el HRHD-Arequipa. Presentado en el XI Congreso Bolivariano de Endocrinología, Lima, marzo 1998

21. Segal HB, et al. El pie del paciente diabético. OPS-OMS. Washington. P. 7-42,1989

22. Krolewski AS, Warram JH, Freire MBS. Epidemiology of late diabetic complications. A basis for the development and evaluation of preventive programs. Endocrinol Metab Clin North Am 25:217,1996

23. Kuzuya T Akanuma Y Akazawa Y, et al. Prevalence of chronic complications in Japanese diabetic patients. Diabetes Res. Clin. Pract Abstract 124:159,1994

24. Warram JH, Masson JE, Krowleski AS. Glycosilated hemoglobin and the risk of retinopathy in insulin-dependent diabetes mellitus. N Engl Med 332:1305,1995

Regresar